Everbright Health Announces Correction to Auditor Opinion Type and Disclosure Notes for Q2 115 Consolidated Financial Report

1. Date of Event: 115/08/14 2. Company Name: Everbright Health Co., Ltd. 3. Relationship with Company (Please enter '本公司' or 'Subsidiary'):本公司 4. Mutual Shareholding Ratio: Not applicable 5. Reason for Occurrence: (1) Correction of auditor opinion type for the Q2 115 consolidated financial report iXBRL (2) Correction of disclosure notes for the Q2 115 financial report announcement 6. Items/Reports to be Corrected: (1) Q2 115 Consolidated Financial Report - Auditor's Review Report (2) Q2 115 Financial Report Announcement Disclosure Notes 7. Information Before Correction (Amount/Content/Page): (1) Q2 115 Consolidated Financial Report - Auditor's Review Report - Qualified Conclusion (Other) (2) The Company's financial statements for the second quarter of 2026 (ROC year 115) have been approved by the Board of Directors and reviewed by Certified Public Accountants Liang Chan-Nu and Cheng Yu-Jen of PricewaterhouseCoopers Taiwan, who issued a qualified conclusion review report in accordance with the Rules for Auditing and Attesting Financial Statements by CPAs and generally accepted auditing standards. 8. Information After Correction (Amount/Content/Page): (1) Q2 115 Consolidated Financial Report - Auditor's Review Report - Qualified Conclusion (Non-material Subsidiaries or Equity Method Investments Not Reviewed by Auditors) (2) The Q2 115 consolidated financial report of the Company has been reviewed by Certified Public Accountants Liang Chan-Nu and Cheng Yu-Jen of PricewaterhouseCoopers Taiwan. A qualified conclusion review report has been issued because the financial statements and related information disclosed in Note 13 for non-material subsidiaries and equity method investments included in the aforementioned consolidated financial statements for the same period have not been reviewed by auditors. The aforementioned reviewed consolidated financial statements have been approved by the Company's Board of Directors and Audit Committee. 9. Response Measures: After issuing the material information announcement, re-upload to the Public Information Observation System. 10. Other Matters to be Disclosed: None